{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:54:06Z","timestamp":1790196846910,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","award":["A2021399"],"award-info":[{"award-number":["A2021399"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s10072-024-07941-7","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T21:14:16Z","timestamp":1734124456000},"page":"1647-1660","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Global, regional and national temporal trends in Parkinson\u2019s disease incidence, disability-adjusted life year rates in middle-aged and older adults: a cross-national inequality analysis and Bayesian age-period-cohort analysis based on the global burden of disease 2021"],"prefix":"10.1007","volume":"46","author":[{"given":"Jian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0756-8486","authenticated-orcid":false,"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,14]]},"reference":[{"issue":"8","key":"7941_CR1","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/mds.25776","volume":"29","author":"E Gelpi","year":"2014","unstructured":"Gelpi E, Navarro-Otano J, Tolosa E et al (2014) Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Mov Disord 29(8):1010\u20131018. https:\/\/doi.org\/10.1002\/mds.25776","journal-title":"Mov Disord"},{"issue":"7","key":"7941_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18(7):435\u2013450. https:\/\/doi.org\/10.1038\/nrn.2017.62","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"7941_CR3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic J (2008) Parkinson\u2019s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79(4):368\u2013376. https:\/\/doi.org\/10.1136\/jnnp.2007.131045","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"7941_CR4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"GBD 2016 Parkinson\u2019s Disease Collaborators","year":"2018","unstructured":"GBD 2016 Parkinson\u2019s Disease Collaborators (2018) Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the global burden of Disease Study 2016. Lancet Neurol 17(11):939\u2013953. https:\/\/doi.org\/10.1016\/S1474-4422(18)30295-3","journal-title":"Lancet Neurol"},{"issue":"10423","key":"7941_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C (2024) The epidemiology of Parkinson\u2019s disease. Lancet 403(10423):283\u2013292. https:\/\/doi.org\/10.1016\/S0140-6736(23)01419-8","journal-title":"Lancet"},{"key":"7941_CR6","doi-asserted-by":"publisher","first-page":"776847","DOI":"10.3389\/fpubh.2021.776847","volume":"9","author":"Z Ou","year":"2021","unstructured":"Ou Z, Pan J, Tang S et al (2021) Global trends in the incidence, prevalence, and years lived with disability of Parkinson\u2019s Disease in 204 Countries\/Territories from 1990 to 2019. Front Public Health 9:776847. https:\/\/doi.org\/10.3389\/fpubh.2021.776847","journal-title":"Front Public Health"},{"issue":"5","key":"7941_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol 20(5):385. https:\/\/doi.org\/10.1016\/S1474-4422(21)00030-2","journal-title":"Lancet Neurol"},{"issue":"8","key":"7941_CR8","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3233\/JPD-230230","volume":"13","author":"JS Yuk","year":"2023","unstructured":"Yuk JS, Jeong SH (2023) Association between Menopausal Hormone Therapy and risk for Parkinson\u2019s Disease. J Parkinsons Dis 13(8):1357\u20131367. https:\/\/doi.org\/10.3233\/JPD-230230","journal-title":"J Parkinsons Dis"},{"key":"7941_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.arr.2017.12.007","volume":"42","author":"H Deng","year":"2018","unstructured":"Deng H, Wang P, Jankovic J (2018) The genetics of Parkinson disease. Ageing Res Rev 42:72\u201385. https:\/\/doi.org\/10.1016\/j.arr.2017.12.007","journal-title":"Ageing Res Rev"},{"issue":"1","key":"7941_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/mds.25150","volume":"28","author":"K Kieburtz","year":"2013","unstructured":"Kieburtz K, Wunderle KB (2013) Parkinson\u2019s disease: evidence for environmental risk factors. Mov Disord 28(1):8\u201313. https:\/\/doi.org\/10.1002\/mds.25150","journal-title":"Mov Disord"},{"issue":"6","key":"7941_CR11","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/mds.27720","volume":"34","author":"C Marras","year":"2019","unstructured":"Marras C, Canning CG, Goldman SM (2019) Environment, lifestyle, and Parkinson\u2019s disease: implications for prevention in the next decade. Mov Disord 34(6):801\u2013811. https:\/\/doi.org\/10.1002\/mds.27720","journal-title":"Mov Disord"},{"issue":"7","key":"7941_CR12","doi-asserted-by":"publisher","first-page":"e0253253","DOI":"10.1371\/journal.pone.0253253","volume":"16","author":"SH Rhew","year":"2021","unstructured":"Rhew SH, Kravchenko J, Lyerly HK (2021) Exposure to low-dose ambient fine particulate matter PM2.5 and Alzheimer\u2019s disease, non-alzheimer\u2019s dementia, and Parkinson\u2019s disease in North Carolina. PLoS ONE 16(7):e0253253. https:\/\/doi.org\/10.1371\/journal.pone.0253253","journal-title":"PLoS ONE"},{"issue":"4","key":"7941_CR13","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/ageing\/aft032","volume":"42","author":"I Akushevich","year":"2013","unstructured":"Akushevich I, Kravchenko J, Ukraintseva S, Arbeev K, Yashin AI (2013) Time trends of incidence of age-associated diseases in the US elderly population: Medicare-based analysis. Age Ageing 42(4):494\u2013500. https:\/\/doi.org\/10.1093\/ageing\/aft032","journal-title":"Age Ageing"},{"issue":"11","key":"7941_CR14","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1093\/aje\/kwv271","volume":"183","author":"SKL Darweesh","year":"2016","unstructured":"Darweesh SKL, Koudstaal PJ, Stricker BH, Hofman A, Ikram MA (2016) Trends in the incidence of Parkinson Disease in the General Population: the Rotterdam Study. Am J Epidemiol 183(11):1018\u20131026. https:\/\/doi.org\/10.1093\/aje\/kwv271","journal-title":"Am J Epidemiol"},{"issue":"3","key":"7941_CR15","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/mds.26862","volume":"32","author":"J Isotalo","year":"2017","unstructured":"Isotalo J, Vahlberg T, Kaasinen V (2017) Unchanged long-term rural-to-urban incidence ratio of Parkinson\u2019s disease. Mov Disord 32(3):474\u2013475. https:\/\/doi.org\/10.1002\/mds.26862","journal-title":"Mov Disord"},{"issue":"10258","key":"7941_CR16","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of Disease Study 2019. Lancet 396(10258):1204\u20131222. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9","journal-title":"Lancet"},{"key":"7941_CR17","doi-asserted-by":"publisher","first-page":"102382","DOI":"10.1016\/j.arr.2024.102382","volume":"99","author":"F Cao","year":"2024","unstructured":"Cao F, Xu Z, Li XX et al (2024) Trends and cross-country inequalities in the global burden of osteoarthritis, 1990\u20132019: a population-based study. Ageing Res Rev 99:102382. https:\/\/doi.org\/10.1016\/j.arr.2024.102382","journal-title":"Ageing Res Rev"},{"issue":"9","key":"7941_CR18","doi-asserted-by":"publisher","first-page":"e713","DOI":"10.1016\/S2352-3026(23)00160-6","volume":"10","author":"GBD 2021 Anaemia Collaborators","year":"2023","unstructured":"GBD 2021 Anaemia Collaborators (2023) Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990\u20132021: findings from the global burden of Disease Study 2021. Lancet Haematol 10(9):e713\u2013e734. https:\/\/doi.org\/10.1016\/S2352-3026(23)00160-6","journal-title":"Lancet Haematol"},{"issue":"4","key":"7941_CR19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"GBD 2021 Nervous System Disorders Collaborators","year":"2024","unstructured":"GBD 2021 Nervous System Disorders Collaborators (2024) Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the global burden of Disease Study 2021. Lancet Neurol 23(4):344\u2013381. https:\/\/doi.org\/10.1016\/S1474-4422(24)00038-3","journal-title":"Lancet Neurol"},{"issue":"12","key":"7941_CR20","doi-asserted-by":"publisher","first-page":"108071","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.108071","volume":"33","author":"J Zhang","year":"2024","unstructured":"Zhang J, Fan Y, Liang H et al (2024) Global, regional, and national temporal trends in metabolism-related ischemic stroke mortality and disability from 1990 to 2021. J Stroke Cerebrovasc Dis 33(12):108071. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2024.108071","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"10159","key":"7941_CR21","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/S0140-6736(18)32225-6","volume":"392","author":"GBD 2017 Risk Factor Collaborators","year":"2018","unstructured":"GBD 2017 Risk Factor Collaborators (2018) Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of Disease Study 2017. Lancet 392(10159):1923\u20131994. https:\/\/doi.org\/10.1016\/S0140-6736(18)32225-6","journal-title":"Lancet"},{"issue":"10440","key":"7941_CR22","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","volume":"403","author":"GBD 2021 Risk Factors Collaborators","year":"2024","unstructured":"GBD 2021 Risk Factors Collaborators (2024) Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of Disease Study 2021. Lancet 403(10440):2162\u20132203. https:\/\/doi.org\/10.1016\/S0140-6736(24)00933-4","journal-title":"Lancet"},{"issue":"1","key":"7941_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12931-022-02011-y","volume":"23","author":"J Zou","year":"2022","unstructured":"Zou J, Sun T, Song X et al (2022) Distributions and trends of the global burden of COPD attributable to risk factors by SDI, age, and sex from 1990 to 2019: a systematic analysis of GBD 2019 data. Respir Res 23(1):90. https:\/\/doi.org\/10.1186\/s12931-022-02011-y","journal-title":"Respir Res"},{"key":"7941_CR24","doi-asserted-by":"publisher","first-page":"113588","DOI":"10.1016\/j.ecoenv.2022.113588","volume":"238","author":"S Sang","year":"2022","unstructured":"Sang S, Chu C, Zhang T, Chen H, Yang X (2022) The global burden of disease attributable to ambient fine particulate matter in 204 countries and territories, 1990\u20132019: a systematic analysis of the global burden of Disease Study 2019. Ecotoxicol Environ Saf 238:113588. https:\/\/doi.org\/10.1016\/j.ecoenv.2022.113588","journal-title":"Ecotoxicol Environ Saf"},{"issue":"12","key":"7941_CR25","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.1038\/s41380-023-02138-4","volume":"28","author":"M Solmi","year":"2023","unstructured":"Solmi M, Seitidis G, Mavridis D et al (2023) Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the global burden of Disease (GBD) 2019. Mol Psychiatry 28(12):5319\u20135327. https:\/\/doi.org\/10.1038\/s41380-023-02138-4","journal-title":"Mol Psychiatry"},{"issue":"3","key":"7941_CR26","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1212\/WNL.0000000000013115","volume":"98","author":"Q Ding","year":"2022","unstructured":"Ding Q, Liu S, Yao Y, Liu H, Cai T, Han L (2022) Global, Regional, and National Burden of ischemic stroke, 1990\u20132019. Neurology 98(3):e279\u2013e290. https:\/\/doi.org\/10.1212\/WNL.0000000000013115","journal-title":"Neurology"},{"issue":"5","key":"7941_CR27","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1161\/STROKEAHA.122.040073","volume":"54","author":"L Pu","year":"2023","unstructured":"Pu L, Wang L, Zhang R, Zhao T, Jiang Y, Han L (2023) Projected global trends in ischemic stroke incidence, deaths and disability-adjusted life years from 2020 to 2030. Stroke 54(5):1330\u20131339. https:\/\/doi.org\/10.1161\/STROKEAHA.122.040073","journal-title":"Stroke"},{"key":"7941_CR28","doi-asserted-by":"publisher","first-page":"106189","DOI":"10.1016\/j.oraloncology.2022.106189","volume":"134","author":"S Zhu","year":"2022","unstructured":"Zhu S, Zhang F, Zhao G et al (2022) Trends in the global burden of oral cancer joint with attributable risk factors: results from the global burden of disease study 2019. Oral Oncol 134:106189. https:\/\/doi.org\/10.1016\/j.oraloncology.2022.106189","journal-title":"Oral Oncol"},{"issue":"1","key":"7941_CR29","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1186\/s12889-024-19337-5","volume":"24","author":"X Chen","year":"2024","unstructured":"Chen X, Zheng J, Wang J et al (2024) Global burden and cross-country inequalities in stroke and subtypes attributable to diet from 1990 to 2019. BMC Public Health 24(1):1813. https:\/\/doi.org\/10.1186\/s12889-024-19337-5","journal-title":"BMC Public Health"},{"issue":"5","key":"7941_CR30","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/jgh.16467","volume":"39","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhu S, Liu C et al (2024) Colorectal cancer and its attributable risk factors in East Asia, 1990\u20132030. J Gastroenterol Hepatol 39(5):880\u2013892. https:\/\/doi.org\/10.1111\/jgh.16467","journal-title":"J Gastroenterol Hepatol"},{"issue":"1861","key":"7941_CR31","doi-asserted-by":"publisher","first-page":"20210242","DOI":"10.1098\/rstb.2021.0242","volume":"377","author":"AA Fisher","year":"2022","unstructured":"Fisher AA, Hassler GW, Ji X, Baele G, Suchard MA, Lemey P (2022) Scalable bayesian phylogenetics. Philosophical Trans Royal Soc B: Biol Sci 377(1861):20210242. https:\/\/doi.org\/10.1098\/rstb.2021.0242","journal-title":"Philosophical Trans Royal Soc B: Biol Sci"},{"issue":"3","key":"7941_CR32","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/bimj.201500263","volume":"59","author":"A Riebler","year":"2017","unstructured":"Riebler A, Held L (2017) Projecting the future burden of cancer: bayesian age-period-cohort analysis with integrated nested Laplace approximations. Biom J 59(3):531\u2013549. https:\/\/doi.org\/10.1002\/bimj.201500263","journal-title":"Biom J"},{"key":"7941_CR33","doi-asserted-by":"publisher","unstructured":"Bai Z, Wang H, Shen C, An J, Yang Z, Mo X (2024) The global, regional, and national patterns of change in the burden of non-malignant upper gastrointestinal diseases from 1990 to 2019 and the forecast for the next decade. Int J Surg Published Online July 3. https:\/\/doi.org\/10.1097\/JS9.0000000000001902","DOI":"10.1097\/JS9.0000000000001902"},{"issue":"1","key":"7941_CR34","doi-asserted-by":"publisher","first-page":"2328521","DOI":"10.1080\/07853890.2024.2328521","volume":"56","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang M, Liu C et al (2024) Global burden of liver cirrhosis 1990\u20132019 and 20 years forecast: results from the global burden of disease study 2019. Ann Med 56(1):2328521. https:\/\/doi.org\/10.1080\/07853890.2024.2328521","journal-title":"Ann Med"},{"issue":"s1","key":"7941_CR35","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR (2018) The emerging evidence of the Parkinson pandemic. J Parkinsons Dis 8(s1):S3\u2013S8. https:\/\/doi.org\/10.3233\/JPD-181474","journal-title":"J Parkinsons Dis"},{"issue":"13","key":"7941_CR36","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim T, Jette N, Frolkis A, Steeves TDL (2014) The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord 29(13):1583\u20131590. https:\/\/doi.org\/10.1002\/mds.25945","journal-title":"Mov Disord"},{"issue":"10033","key":"7941_CR37","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/S0140-6736(15)00516-4","volume":"387","author":"JR Beard","year":"2016","unstructured":"Beard JR, Officer A, de Carvalho IA et al (2016) The World report on ageing and health: a policy framework for healthy ageing. Lancet 387(10033):2145\u20132154. https:\/\/doi.org\/10.1016\/S0140-6736(15)00516-4","journal-title":"Lancet"},{"issue":"2","key":"7941_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"GBD 2019 Mental Disorders Collaborators","year":"2022","unstructured":"GBD 2019 Mental Disorders Collaborators (2022) Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of Disease Study 2019. Lancet Psychiatry 9(2):137\u2013150. https:\/\/doi.org\/10.1016\/S2215-0366(21)00395-3","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"7941_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00415-007-0655-z","volume":"255","author":"X Li","year":"2008","unstructured":"Li X, Sundquist J, Hwang H, Sundquist K (2008) Impact of psychiatric disorders on Parkinson\u2019s disease: a nationwide follow-up study from Sweden. J Neurol 255(1):31\u201336. https:\/\/doi.org\/10.1007\/s00415-007-0655-z","journal-title":"J Neurol"},{"issue":"7721","key":"7941_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41586-018-0457-8","volume":"561","author":"L Partridge","year":"2018","unstructured":"Partridge L, Deelen J, Slagboom PE (2018) Facing up to the global challenges of ageing. Nature 561(7721):45\u201356. https:\/\/doi.org\/10.1038\/s41586-018-0457-8","journal-title":"Nature"},{"issue":"10053","key":"7941_CR41","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1016\/S0140-6736(16)31467-2","volume":"388","author":"GBD 2015 SDG Collaborators","year":"2016","unstructured":"GBD 2015 SDG Collaborators (2016) Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the global burden of Disease Study 2015. Lancet 388(10053):1813\u20131850. https:\/\/doi.org\/10.1016\/S0140-6736(16)31467-2","journal-title":"Lancet"},{"issue":"9","key":"7941_CR42","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S2213-2600(17)30293-X","volume":"5","author":"GBD 2015 Chronic Respiratory Disease Collaborators","year":"2017","unstructured":"GBD 2015 Chronic Respiratory Disease Collaborators (2017) Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990\u20132015: a systematic analysis for the global burden of Disease Study 2015. Lancet Respir Med 5(9):691\u2013706. https:\/\/doi.org\/10.1016\/S2213-2600(17)30293-X","journal-title":"Lancet Respir Med"},{"issue":"10311","key":"7941_CR43","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/S0140-6736(21)01546-4","volume":"398","author":"GBD 2019 Adolescent Mortality Collaborators","year":"2021","unstructured":"GBD 2019 Adolescent Mortality Collaborators (2021) Global, regional, and national mortality among young people aged 10\u201324 years, 1950\u20132019: a systematic analysis for the global burden of Disease Study 2019. Lancet 398(10311):1593\u20131618. https:\/\/doi.org\/10.1016\/S0140-6736(21)01546-4","journal-title":"Lancet"},{"issue":"10","key":"7941_CR44","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/mds.26728","volume":"31","author":"SC LaHue","year":"2016","unstructured":"LaHue SC, Comella CL, Tanner CM (2016) The best medicine? The influence of physical activity and inactivity on Parkinson\u2019s disease. Mov Disord 31(10):1444\u20131454. https:\/\/doi.org\/10.1002\/mds.26728","journal-title":"Mov Disord"},{"key":"7941_CR45","doi-asserted-by":"publisher","first-page":"110609","DOI":"10.1016\/j.nut.2019.110609","volume":"71","author":"EE Mart\u00ednez Leo","year":"2020","unstructured":"Mart\u00ednez Leo EE, Segura Campos MR (2020) Effect of ultra-processed diet on gut microbiota and thus its role in neurodegenerative diseases. Nutrition 71:110609. https:\/\/doi.org\/10.1016\/j.nut.2019.110609","journal-title":"Nutrition"},{"issue":"9","key":"7941_CR46","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/aje\/kwk089","volume":"165","author":"H Chen","year":"2007","unstructured":"Chen H, O\u2019Reilly E, McCullough ML et al (2007) Consumption of dairy products and risk of Parkinson\u2019s disease. Am J Epidemiol 165(9):998\u20131006. https:\/\/doi.org\/10.1093\/aje\/kwk089","journal-title":"Am J Epidemiol"},{"issue":"11","key":"7941_CR47","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s10654-018-0399-3","volume":"33","author":"T Vlaar","year":"2018","unstructured":"Vlaar T, Kab S, Schwaab Y, Fr\u00e9ry N, Elbaz A, Moisan F (2018) Association of Parkinson\u2019s disease with industry sectors: a French nationwide incidence study. Eur J Epidemiol 33(11):1101\u20131111. https:\/\/doi.org\/10.1007\/s10654-018-0399-3","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"7941_CR48","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1289\/ehp.1002839","volume":"119","author":"CM Tanner","year":"2011","unstructured":"Tanner CM, Kamel F, Ross GW et al (2011) Rotenone, paraquat, and Parkinson\u2019s disease. Environ Health Perspect 119(6):866\u2013872. https:\/\/doi.org\/10.1289\/ehp.1002839","journal-title":"Environ Health Perspect"},{"issue":"2","key":"7941_CR49","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3233\/JPD-225047","volume":"13","author":"ER Dorsey","year":"2023","unstructured":"Dorsey ER, Zafar M, Lettenberger SE et al (2023) Trichloroethylene: an Invisible cause of Parkinson\u2019s Disease? J Parkinsons Dis 13(2):203\u2013218. https:\/\/doi.org\/10.3233\/JPD-225047","journal-title":"J Parkinsons Dis"},{"issue":"47","key":"7941_CR50","doi-asserted-by":"publisher","first-page":"44284","DOI":"10.1074\/jbc.M105343200","volume":"276","author":"VN Uversky","year":"2001","unstructured":"Uversky VN, Li J, Fink AL (2001) Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson\u2019s disease and heavy metal exposure. J Biol Chem 276(47):44284\u201344296. https:\/\/doi.org\/10.1074\/jbc.M105343200","journal-title":"J Biol Chem"},{"key":"7941_CR51","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.puhe.2019.09.020","volume":"179","author":"C Han","year":"2020","unstructured":"Han C, Lu Y, Cheng H, Wang C, Chan P (2020) The impact of long-term exposure to ambient air pollution and second-hand smoke on the onset of Parkinson disease: a review and meta-analysis. Public Health 179:100\u2013110. https:\/\/doi.org\/10.1016\/j.puhe.2019.09.020","journal-title":"Public Health"},{"issue":"1","key":"7941_CR52","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1515\/reveh-2021-0111","volume":"38","author":"T Chambers-Richards","year":"2023","unstructured":"Chambers-Richards T, Su Y, Chireh B, D\u2019Arcy C (2023) Exposure to toxic occupations and their association with Parkinson\u2019s disease: a systematic review with meta-analysis. Rev Environ Health 38(1):65\u201383. https:\/\/doi.org\/10.1515\/reveh-2021-0111","journal-title":"Rev Environ Health"},{"key":"7941_CR53","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yrtph.2018.05.005","volume":"96","author":"D Yan","year":"2018","unstructured":"Yan D, Zhang Y, Liu L, Shi N, Yan H (2018) Pesticide exposure and risk of Parkinson\u2019s disease: dose-response meta-analysis of observational studies. Regul Toxicol Pharmacol 96:57\u201363. https:\/\/doi.org\/10.1016\/j.yrtph.2018.05.005","journal-title":"Regul Toxicol Pharmacol"},{"issue":"12","key":"7941_CR54","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1002\/mds.28762","volume":"36","author":"S Qi","year":"2021","unstructured":"Qi S, Yin P, Wang L et al (2021) Prevalence of Parkinson\u2019s Disease: A Community-based study in China. Mov Disord 36(12):2940\u20132944. https:\/\/doi.org\/10.1002\/mds.28762","journal-title":"Mov Disord"},{"issue":"11","key":"7941_CR55","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1002\/mds.21898","volume":"23","author":"C Dotchin","year":"2008","unstructured":"Dotchin C, Msuya O, Kissima J et al (2008) The prevalence of Parkinson\u2019s disease in rural Tanzania. Mov Disord 23(11):1567\u20131672. https:\/\/doi.org\/10.1002\/mds.21898","journal-title":"Mov Disord"},{"issue":"4","key":"7941_CR56","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1212\/wnl.46.4.1044","volume":"46","author":"DM Morens","year":"1996","unstructured":"Morens DM, Davis JW, Grandinetti A, Ross GW, Popper JS, White LR (1996) Epidemiologic observations on Parkinson\u2019s disease: incidence and mortality in a prospective study of middle-aged men. Neurology 46(4):1044\u20131050. https:\/\/doi.org\/10.1212\/wnl.46.4.1044","journal-title":"Neurology"},{"issue":"10","key":"7941_CR57","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1007\/s11064-007-9324-y","volume":"32","author":"V Bonifati","year":"2007","unstructured":"Bonifati V (2007) LRRK2 low-penetrance mutations (Gly2019Ser) and risk alleles (Gly2385Arg)-linking familial and sporadic Parkinson\u2019s disease. Neurochem Res 32(10):1700\u20131708. https:\/\/doi.org\/10.1007\/s11064-007-9324-y","journal-title":"Neurochem Res"},{"key":"7941_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pbr.2024.06.001","volume":"289","author":"AO Asuku","year":"2024","unstructured":"Asuku AO, Ayinla MT, Olajide TS et al (2024) Coffee and Parkinson\u2019s disease. Prog Brain Res 289:1\u201319. https:\/\/doi.org\/10.1016\/bs.pbr.2024.06.001","journal-title":"Prog Brain Res"},{"issue":"3 Suppl","key":"7941_CR59","doi-asserted-by":"publisher","first-page":"S238","DOI":"10.1016\/j.apmr.2013.08.298","volume":"95","author":"C Marras","year":"2014","unstructured":"Marras C, Hincapi\u00e9 CA, Kristman VL et al (2014) Systematic review of the risk of Parkinson\u2019s disease after mild traumatic brain injury: results of the International collaboration on mild traumatic brain Injury Prognosis. Arch Phys Med Rehabil 95(3 Suppl):S238\u2013244. https:\/\/doi.org\/10.1016\/j.apmr.2013.08.298","journal-title":"Arch Phys Med Rehabil"},{"issue":"2","key":"7941_CR60","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.yhbeh.2012.05.013","volume":"63","author":"R Savica","year":"2013","unstructured":"Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA (2013) Risk factors for Parkinson\u2019s disease may differ in men and women: an exploratory study. Horm Behav 63(2):308\u2013314. https:\/\/doi.org\/10.1016\/j.yhbeh.2012.05.013","journal-title":"Horm Behav"},{"issue":"3","key":"7941_CR61","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3233\/JPD-202522","volume":"11","author":"J Sieurin","year":"2021","unstructured":"Sieurin J, Zhan Y, Pedersen NL, Wirdefeldt K (2021) Neuroticism, Smoking, and the risk of Parkinson\u2019s Disease. J Parkinsons Dis 11(3):1325\u20131334. https:\/\/doi.org\/10.3233\/JPD-202522","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"7941_CR62","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/oxfordjournals.bmb.a011533","volume":"52","author":"JA Baron","year":"1996","unstructured":"Baron JA (1996) Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious. Br Med Bull 52(1):58\u201373. https:\/\/doi.org\/10.1093\/oxfordjournals.bmb.a011533","journal-title":"Br Med Bull"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07941-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-024-07941-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07941-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T13:53:26Z","timestamp":1742306006000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-024-07941-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,14]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["7941"],"URL":"https:\/\/doi.org\/10.1007\/s10072-024-07941-7","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,14]]},"assertion":[{"value":"24 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study utilized publicly available data from participant studies on human subjects, all of which were approved by the Ethical Standards Committee. No additional ethical approval was necessary for this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no relevant disclosures pertaining to this manuscript. The views presented in the submitted article reflect the authors\u2019 own statements and do not represent the official stance of the institution or funding agency.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The authors declare that they have no known financial conflicts of interest or personal relationships that could have influenced the work reported in this paper. Additionally, no support from any organization or related activities was received for the submitted work.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}